USMCA Drops Biologic Exclusivity Provisions for Mexico and Canada in Final Deal

The new trade agreement between the US, Mexico and Canada, signed Tuesday in Mexico City, dealt a blow to the biopharma industry as the final deal no longer includes provisions that would have extended the exclusivity of biologics in Canada and Mexico.